Logotype for CRH plc

CRH (CRH) H2 2016 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for CRH plc

H2 2016 earnings summary

19 Nov, 2026

Executive summary

  • 2016 delivered reported sales growth of 15% and EBITDA growth of 41%, with organic growth, acquisition contributions, margin gains, cash generation and debt reduction supporting performance.

  • Pro forma EBITDA growth was ~10% for the year; organic operating leverage reached 35%, above historical norms.

  • Improved margins and returns across regions were driven by portfolio reshaping and commercial and operational initiatives, alongside recovering markets in the Americas.

Financial highlights

  • Sales exceeded €27bn, up 15% YoY; EBITDA exceeded €3.1bn, up 41% YoY.

  • Organic sales increased €684m and organic EBITDA increased €239m; organic operating leverage was 35%.

  • Operating cash generation was €2.3bn, with EBITDA-to-cash conversion of 75%.

  • Currency was a €70m EBITDA headwind, including €50m from sterling.

Outlook and guidance

  • 2017 outlook: continued progress in Europe, Americas volume and pricing growth broadly in line with 2016, and further improvement in Asia.

  • Long-term operating leverage guidance remains 15%–20%; 2017 is expected to face a tough H1 comparison after strong H1 2016 pro forma growth of 20%.

  • Expected 2017 effective tax rate is 27%–28%; interest expense was expected to remain relatively stable.

  • CapEx guidance was ~100% of depreciation on average, with planned Philippines capacity investment likely to take spending above that level over the next 2–3 years.

  • Progressive dividend policy; per-share dividend growth is expected to lag EPS growth while cover is rebuilt toward ~3x over the medium term from just over 2x.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CRH